Altered emotional and motivational processing in the transgenic rat model for Huntington's disease

Neurobiology of Learning and Memory

Volumn 95, Issue 1, 2011, Pages 92-101

  Faure, A ^a,b   Hohn S ^a,b   Von Horsten S ^c   Delatour, B ^a,d   Raber, K ^c   Le Blanc, P ^a,b   Desvignes, N ^a,b   Doyere V ^a,b   El Massioui, N ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Affective perception; Behavior; Fear conditioning; Hedonic; Neurodegeneration; Taste reactivity

Indexed keywords

SUCROSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CENTRAL NUCLEUS (AMYGDALA); COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; CORPUS STRIATUM; EMOTIONALITY; FACE VALIDITY; FEAR; FRUSTRATION; HUNTINGTON CHOREA; HYPERSENSITIVITY; LEARNING; MOTIVATION; MOTOR PERFORMANCE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; RAT; REINFORCEMENT; TRANSGENIC ANIMAL; TRANSGENIC RAT; WILD TYPE;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, CLASSICAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; EMOTIONS; EXTINCTION, PSYCHOLOGICAL; HUNTINGTON DISEASE; MOTIVATION; MOTOR ACTIVITY; MOTOR SKILLS; NUCLEUS ACCUMBENS; RATS; RATS, TRANSGENIC;

EID: 78651230354     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2010.11.010     Document Type: Article

References (63)

1. Aguilar R., Gil L., Flint J., Gray J.A., Dawson G.R., Driscoll P., et al. Learned fear, emotional reactivity and fear of heights: A factor analytic map from a large F(2) intercross of Roman rat strains. Brain Res Bull 2002, 57:17-26.
2. Amsel A. Frustrative nonreward in partial reinforcement and discrimination learning: Some recent history and a theoretical extension. Psychol Rev 1962, 69:306-328.
3. Berridge K.C. Measuring hedonic impact in animals and infants: Microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev 2000, 24:173-198.
4. Bode F.J., Stephan M., Suhling H., Pabst R., Straub R.H., Raber K.A., et al. Sex differences in a transgenic rat model of Huntington's disease: Decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum Mol Genet 2008, 17:2595-2609.
5. Bolivar V.J., Manley K., Messer A. Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice. Behav Neurosci 2003, 117:1233-1242.
6. Bots G.T., Bruyn G.W. Neuropathological changes of the nucleus accumbens in Huntington's chorea. Acta Neuropathol 1981, 55:21-22.
7. Brown B.L., Richer P., Doyere V. The effect of an intruded event on peak-interval timing in rats: Isolation of a postcue effect. Behav Process 2007, 74:300-310.
8. Cepeda C., Hurst R.S., Calvert C.R., Hernandez-Echeagaray E., Nguyen O.K., Jocoy E., et al. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 2003, 23:961-969.
9. Ciamei A., Morton A.J. Rigidity in social and emotional memory in the R6/2 mouse model of Huntington's disease. Neurobiol Learn Mem 2008, 89:533-544.
10. de la Monte S.M., Vonsattel J.P., Richardson E.P. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988, 47:516-525.
11. Delatour B., Gisquet-Verrier P. Prelimbic cortex specific lesions disrupt delayed-variable response tasks in the rat. Behav Neurosci 1996, 110:1282-1298.
12. Deng Y.P., Albin R.L., Penney J.B., Young A.B., Anderson K.D., Reiner A. Differential loss of striatal projection systems in Huntington's disease: A quantitative immunohistochemical study. J Chem Neuroanat 2004, 27:143-164.
13. Douaud G., Gaura V., Ribeiro M.J., Lethimonnier F., Maroy R., Verny C., et al. Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI-based and voxel-based morphometric study. Neuroimage 2006, 32:1562-1575.
14. Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. Ann NY Acad Sci 1999, 877:614-637.
15. Drevets Wayne.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann NY Acad Sci 2003, 985:420-444.
16. Duff K., Paulsen J.S., Beglinger L.J., Langbehn D.R., Stout J.C. Psychiatric symptoms in Huntington's disease before diagnosis: The predict-HD study. Biol Psychiatry 2007, 62:1341-1346.
17. Faure A., Richard J.M., Berridge K.C. Desire and dread from the nucleus accumbens: Cortical glutamate and subcortical GABA differentially generate motivation and hedonic impact in the rat. PLoS One 2010, 5:e11223.
18. File S.E., Mahal A., Mangiarini L., Bates G.P. Striking changes in anxiety in Huntington's disease transgenic mice. Brain Res 1998, 805:234-240.
19. Folstein S., Abbott M.H., Chase G.A., Jensen B.A., Folstein M.F. The association of affective disorder with Huntington's disease in a case series and in families. Psychol Med 1983, 13:537-542.
20. Hickey M.A., Chesselet M.F. The use of transgenic and knock-in mice to study Huntington's disease. Cytogenet Genome Res 2003, 100:276-286.
21. Hickey M.A., Gallant K., Gross G.G., Levine M.S., Chesselet M.F. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol Dis 2005, 20:1-11.
22. Hickey M.A., Kosmalska A., Enayati J., Cohen R., Zeitlin S., Levine M.S., et al. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience 2008, 157:280-295.
23. Kantor O., Temel Y., Holzmann C., Raber K., Nguyen H.P., Cao C., et al. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiol Dis 2006, 22:538-547.
24. Kingma E.M., van Duijn E., Timman R., van der Mast R.C., Roos R.A. Behavioural problems in Huntington's disease using the problem behaviours assessment. Gen Hosp Psychiat 2008, 30:155-161.
25. Laforet G.A., Sapp E., Chase K., McIntyre C., Boyce F.M., Campbell M., et al. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J Neurosci 2001, 21:9112-9123.
26. Lange H., Thorner G., Hopf A., Schroder K.F. Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 1976, 28:401-425.
27. Laviola G., Hannan A.J., Macri S., Solinas M., Jaber M. Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol Dis 2008, 31:159-168.
28. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
29. LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 2003, 23:727-738.
30. Menalled L., El-Khodor B.F., Patry M., Suarez-Farinas M., Orenstein S.J., Zahasky B., et al. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol Dis 2009, 35:319-336.
31. Miller B.R., Walker A.G., Fowler S.C., von Horsten S., Riess O., Johnson M.A., et al. Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease. Neurobiol Dis 2008, 37:106-113.
32. Morgan M.A., Romanski L.M., LeDoux J.E. Extinction of emotional learning: Contribution of medial prefrontal cortex. Neurosci Lett 1993, 163:109-113.
33. Nguyen H.P., Kobbe P., Rahne H., Worpel T., Jager B., Stephan M., et al. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet 2006, 15:3177-3194.
34. Paradiso S., Turner B.M., Paulsen J.S., Jorge R., Ponto L.L., Robinson R.G. Neural bases of dysphoria in early Huntington's disease. Psychiat Res 2008, 162:73-87.
35. Pare D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. J Neurophysiol 2004, 92:1-9.
36. Paulsen J.S., Ready R.E., Hamilton J.M., Mega M.S., Cummings J.L. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiat 2001, 71:310-314.
37. Pavese N., Andrews T.C., Brooks D.J., Ho A.K., Rosser A.E., Barker R.A., et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A PET study. Brain 2003, 126:1127-1135.
38. Paxinos, G., Watson, C. (2004). The Rat Brain in Stereotaxic Coordinates. (5 ed.): Elsevier.
39. Pecina S., Berridge K.C. Hedonic hot spot in nucleus accumbens shell: Where do mu-opioids cause increased hedonic impact of sweetness?. J Neurosci 2005, 25:11777-11786.
40. Pecina S., Cagniard B., Berridge K.C., Aldridge J.W., Zhuang X. Hyperdopaminergic mutant mice have higher " wanting" but not " liking" for sweet rewards. J Neurosci 2003, 23:9395-9402.
41. Pecina S., Smith K.S., Berridge K.C. Hedonic hot spots in the brain. Neuroscientist 2006, 12:500-511.
42. Petrasch-Parwez E., Nguyen H.P., Lobbecke-Schumacher M., Habbes H.W., Wieczorek S., Riess O., et al. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. J Comp Neurol 2007, 501:716-730.
43. Pouladi M.A., Graham R.K., Karasinska J.M., Xie Y., Santos R.D., Petersen A., et al. Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain 2009, 132:919-932.
44. Quirk G.J., Beer J.S. Prefrontal involvement in the regulation of emotion: Convergence of rat and human studies. Curr Opin Neurobiol 2006, 16:723-727.
45. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 1988, 85:5733-5737.
46. Reynolds S.M., Berridge K.C. Positive and negative motivation in nucleus accumbens shell: Bivalent rostrocaudal gradients for GABA-elicited eating, taste " liking" /" disliking" reactions, place preference/avoidance, and fear. J Neurosci 2002, 22:7308-7320.
47. Roozendaal B., Wiersma A., Driscoll P., Koolhaas J.M., Bohus B. Vasopressinergic modulation of stress responses in the central amygdala of the Roman high-avoidance and low-avoidance rat. Brain Res 1992, 596:35-40.
48. Rosas J.M., Callejas-Aguilera J.E., Escarabajal M.D., Gomez M.J., de la Torre L., Aguero A., et al. Successive negative contrast effect in instrumental runway behaviour: A study with Roman high- (RHA) and Roman low- (RLA) avoidance rats. Behav Brain Res 2007, 185:1-8.
49. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., et al. Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis. Neurology 2003, 60:1615-1620.
50. Rudenko O., Tkach V., Berezin V., Bock E. Detection of early behavioral markers of Huntington's disease in R6/2 mice employing an automated social home cage. Behav Brain Res 2009, 203:188-199.
51. Salinas J.A., White N.M. Contributions of the hippocampus, amygdala, and dorsal striatum to the response elicited by reward reduction. Behav Neurosci 1998, 112:812-826.
52. Snowden J.S., Austin N.A., Sembi S., Thompson J.C., Craufurd D., Neary D. Emotion recognition in Huntington's disease and frontotemporal dementia. Neuropsychologia 2008, 46:2638-2649.
53. Sprengelmeyer R., Schroeder U., Young A.W., Epplen J.T. Disgust in pre-clinical Huntington's disease: A longitudinal study. Neuropsychologia 2006, 44:518-533.
54. Sprengelmeyer R., Young A.W., Calder A.J., Karnat A., Lange H., Homberg V., et al. Loss of disgust. Perception of faces and emotions in Huntington's disease. Brain 1996, 119(Pt 5):1647-1665.
55. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol 2009, 8:791-801.
56. Thompson J.C., Snowden J.S., Craufurd D., Neary D. Behavior in Huntington's disease: Dissociating cognition-based and mood-based changes. J Neuropsychiat Clin Neurosci 2002, 14:37-43.
57. Torres C., Candido A., Escarabajal M.D., de la Torre L., Maldonado A., Tobena A., et al. Successive negative contrast in one-way avoidance learning in female Roman rats. Physiol Behav 2005, 85:377-382.
58. Urbach Y.K., Bode F.J., Nguyen H.P., Riess O., von Horsten S. Neurobehavioral tests in rat models of degenerative brain diseases. Methods Mol Biol 2010, 597:333-356.
59. von Horsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., et al. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003, 12:617-624.
60. Walker A.G., Miller B.R., Fritsch J.N., Barton S.J., Rebec G.V. Altered information processing in the prefrontal cortex of Huntington's disease mouse models. J Neurosci 2008, 28:8973-8982.
61. Wang K., Hoosain R., Yang R.M., Meng Y., Wang C.Q. Impairment of recognition of disgust in Chinese with Huntington's or Wilson's disease. Neuropsychologia 2003, 41:527-537.
62. Yokoi F., Dang M.T., Miller C.A., Marshall A.G., Campbell S.L., Sweatt J.D., et al. Increased c-fos expression in the central nucleus of the amygdala and enhancement of cued fear memory in Dyt1 DeltaGAG knock-in mice. Neurosci Res 2009, 65:228-235.
63. Zinzi P., Salmaso D., De Grandis R., Graziani G., Maceroni S., Bentivoglio A., et al. Effects of an intensive rehabilitation programme on patients with Huntington's disease: A pilot study. Clin Rehabil 2007, 21:603-613.